Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1428-1434

  Perez G , Moises ^a   Melo, Marco ^a   Keegan, Achsah D ^a   Zamorano, Jose ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD23 ANTIGEN; ENZYME INHIBITOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; JANUS KINASE; PROTEASOME INHIBITOR; PROTEIN TYROSINE KINASE; SALICYLIC ACID DERIVATIVE; STAT6 PROTEIN;

ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036467550     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1428     Document Type: Article

References (48)

1. Allergy and allergic diseases
2. Mechanisms of enhanced prevalence of asthma and atopy in developed countries
3. The inverse association between tuberculin responses and atopic disorder
4. Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood: A prospective study
5. Hypothesis: Decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma
6. Asthma and wheezing in the first six years of life
7. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: Reappraisal of the role of infections and air pollution
8. Air pollution and upper respiratory symptoms in children from East Germany
9. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood
10. Analgesic-antipyretics and anti-inflammatory agents: Drugs employed in the treatment of gout
11. Aspirin and Reyes syndrome
12. Asthma improved by aspirin-like drugs
13. Inhaled lysine acetylsalicylate (L-ASA) attenuates histamine-induced bronchoconstriction in asthma
14. Different effects of inhaled aspirin-like drugs on allergen-induced early and late asthmatic responses
15. Salicylate pretreatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients
16. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes
17. Aspirin-induced asthma: Advances in pathogenesis and management
18. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced -κBα phosphorylation and degradation
19. The anti-inflammatory agents aspirin and salicylate inhibit the activity of lκB kinase-β
20. Inhibition of NF-κB by sodium salicylate and aspirin
21. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin
22. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite N. brasiliensis
23. Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production
24. An antagonistic IL-4 mutant prevent type I allergy in the mouse: Inhibition of the IL-4-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo
25. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
26. Soluble IL-4R inhibits airway inflammation following allergen challenge in a mouse model of asthma
27. Interleukin-2 receptor γ-chain: A functional component of the interleukin-4 receptor
28. Cloning of the human IL-13Rα1 chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex
29. Jakl expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules
30. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways
31. Interleukin-13: Central mediator of allergic asthma
32. Requirement for IL-13 independently of IL-4 in experimental asthma
33. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production
34. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
35. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor
36. A small amphipathic α-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated STAT5
37. Protein tyrosine phosphatase activity is required for IL-4 induction of IL-4R α-chain
38. Interleukin-4-induced transcriptional activation by STAT6 involves multiple serine/threonine kinase pathways and serine phosphorylation of STAT6
39. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines
40. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine Kinase
41. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation
42. Possible role of tyrosine kinase activity in interleukin 4-induced expression of germ-line Cε transcripts in a human Burkett lymphoma B-cell line, DND39
43. Salicylate inhibits phosphorylation of the nonreceptor tyrosine kinases, proline-rich tyrosine kinase 2 and c-Src
44. The instability of polyhydroxylated aromatic protein tyrosine kinase inhibitors in the presence of manganese
45. Salicylateenhanced activation of transcription factors induced by interferon-γ
46. Aspirin and asthma
47. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma
48. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma